Amwill Health Care Stock Screener | Share Price & Fundamental Analysis
AMWILL
Pharmaceuticals
Screen Amwill Health Care share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹95.26 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.28
EPS (TTM)
₹6.63
Dividend Yield
-
Debt to Equity
-
52W High
-
52W Low
-
Operating Margin
6.00%
Profit Margin
25.00%
Revenue (TTM)
₹8.00
EBITDA
₹2.00
Net Income
₹2.00
Total Assets
₹72.00
Total Equity
₹69.00
Amwill Health Care Share Price History - Stock Screener Chart
Screen AMWILL historical share price movements with interactive charts. Analyze price trends and patterns.
Amwill Health Care Company Profile - Fundamental Screener
Screen Amwill Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMWILL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0U2L01017
Amwill Health Care Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen AMWILL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 72 | 19 | 12 | 7 | 8 |
| Current Assets | 22 | 18 | 11 | 6 | 7 |
| Fixed Assets | 1 | 1 | 1 | 0 | 1 |
| Liabilities | |||||
| Total Liabilities | 72 | 19 | 12 | 7 | 8 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 69 | 17 | 5 | 2 | -1 |
| Share Capital | 20 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 49 | 17 | 5 | 2 | -1 |
Screen AMWILL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
| Revenue | 8 | 41 | 44 | 30 | 28 | 18 |
| Expenses | 6 | 29 | 27 | 26 | 24 | 19 |
| EBITDA | 2 | 12 | 17 | 4 | 4 | -1 |
| Operating Profit % | 6.00% | 29.00% | 38.00% | 14.00% | 13.00% | -6.00% |
| Depreciation | 0 | 1 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 12 | 17 | 4 | 3 | -1 |
| Tax | 1 | 1 | 4 | 1 | 1 | 0 |
| Net Profit | 2 | 11 | 13 | 3 | 3 | -1 |
| EPS | 299.20 | 6.63 | 8.01 | 2.00 | 1.65 | -0.64 |
Amwill Health Care Cash Flow Screener - Liquidity Fundamentals
Screen AMWILL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | 6 | -3 | 5 | 3 | 0 |
| Investing Activities | -46 | -1 | -1 | 0 | -1 |
| Financing Activities | 41 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 1 | -5 | 3 | 3 | -1 |
Screen AMWILL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Mar | 2025-Feb | 2025-Jan | 2024-May |
|---|---|---|---|---|---|
| Promoter Holding | 70.65% | 70.65% | 97.00% | 97.00% | 97.00% |
| FII Holding | 1.16% | 1.16% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.85% | 21.14% | 0.00% | 0.00% | 0.00% |
| Other Holding | 3.34% | 7.05% | 3.00% | 3.00% | 3.00% |
| Shareholder Count | 1,606 | 1,374 | 7 | 7 | 7 |
Amwill Health Care Dividend Screener - Share Yield Analysis
Screen AMWILL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Amwill Health Care Index Membership - Market Screener Classification
Screen AMWILL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Amwill Health Care Market Events Screener - Corporate Actions
Screen AMWILL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 6.51% |
| 2025-08-14 | 2025-08-14 | Annual General Meeting | NA | -6.05% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.56% |
Amwill Health Care Competitors Screener - Peer Comparison
Screen AMWILL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,614 | 39.35 | 54,729 | 9.71% | 10,980 | 38.94 |
| Divis Laboratories | 169,701 | 68.64 | 9,712 | 18.67% | 2,191 | 47.61 |
| Torrent Pharmaceuticals | 130,301 | 60.42 | 11,539 | 6.99% | 1,911 | 63.27 |
| Cipla | 122,079 | 22.17 | 28,410 | 7.12% | 5,291 | 50.85 |
| Dr Reddys Laboratories | 106,115 | 18.42 | 33,741 | 16.73% | 5,725 | 53.02 |
| Lupin | 96,362 | 21.87 | 22,910 | 13.74% | 3,306 | 57.47 |
| Zydus Life Science | 92,005 | 18.03 | 23,511 | 18.55% | 4,615 | 43.59 |
| Mankind Pharma | 90,673 | 50.11 | 12,744 | 20.90% | 2,007 | 49.10 |
| Aurobindo Pharma | 68,709 | 20.16 | 32,346 | 9.43% | 3,484 | 45.26 |
| Alkem Laboratories | 65,838 | 26.89 | 13,458 | 3.70% | 2,216 | 41.76 |
Amwill Health Care Company Announcements - News Screener
Screen AMWILL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-04 | SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (IPO") | View |
| 2025-11-04 | Unaudited Financial Results For The Half Year Ended September 30 2025. | View |
| 2025-11-04 | Board Meeting Outcome for Board Meeting Outcome For The Meeting Of The Board Of Directors Held On November 04 2025 | View |
| 2025-10-30 | Board Meeting Intimation for For Convening The Board Meeting On Thursday October 30 2025 For Consideration And Approval Of Unaudited Financial Results For H1 FY26 Has Been Rescheduled And Will Now Be Held On Tuesday November 04 2025. | View |
| 2025-10-24 | Board Meeting Intimation for Convening The Board Meeting On Thursday October 30 2025 For Consideration And Approval Of Unaudited Financial Results For H1 FY26. | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-08-14 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-08-14 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-07-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-07-18 | Reg. 34 (1) Annual Report. | View |
| 2025-07-18 | Notice Of 08Th Annual General Meeting And Annual Report For FY 2024-25 | View |
| 2025-07-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-07-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-07-08 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On July 08 2025 | View |
| 2025-06-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-05-29 | SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (IPO") | View |
| 2025-05-29 | Audited Financial Results For The Half Year And Year Ended March 31 2025. | View |
| 2025-05-29 | Board Meeting Outcome for Board Meeting Intimation To Consider And Approve The Half Year And Yearly Audited Financial Results Of The Company For The Period Ended March 31St 2025. | View |
| 2025-05-26 | Board Meeting Intimation for Board Meeting Intimation For Audited Financial Results For Half Yeraly And Yearly For The Period Ened March 31 2025 Of The Company. | View |